o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

Clinical trial NCT07333976 · COMPLETED

Trial details

NCT number: NCT07333976
Sponsor: Tri-Service General Hospital (TSGH)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Disease Chemotherapy Induced Peripheral Neuropathy (CIPN)Neurotoxicity

Start date: 2020-01-05
Primary completion: 2023-12-22
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.